Journal article
Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001–2009)
Abstract
BACKGROUND: Quality-of-life (QOL) measurement is often incorporated into randomized clinical trials in breast cancer. The objectives of this systematic review were to assess the incremental effect of QOL measurement in addition to traditional endpoints (such as disease-free survival or toxic effects) on clinical decision making and to describe the extent of QOL reporting in randomized clinical trials of breast cancer.
METHODS: We conducted a …
Authors
Lemieux J; Goodwin PJ; Bordeleau LJ; Lauzier S; Théberge V
Journal
Journal of the National Cancer Institute, Vol. 103, No. 3, pp. 178–231
Publisher
Oxford University Press (OUP)
Publication Date
February 2, 2011
DOI
10.1093/jnci/djq508
ISSN
0027-8874